On May 3, 2018, the USPTO’s Patent Trial and Appeal Board (“Board”) issued a decision in an inter partes review regarding a petition filed by St. Jude Medical, LLC (“Petitioner”). In the decision, the Board granted the institution of the inter partes review, which involved the patentability of claims 18 and 20 recited in U.S. Patent No. 6,821,297 (“the ‘297 Patent”). The ‘297 Patent is owned by Snyders Heart Valve LLC and is drawn to an artificial heart valve and implantation instrument. In the decision, the Board granted the institution of the inter partes review because the Petitioner had demonstrated a reasonable likelihood of prevailing in showing that the challenged claims were unpatentable under 35 U.S.C. §§ 102 and/or 103. The inter partes review remains pending at the Board and is captioned IPR2018-00109.
By: Jacqueline A. DiRamio